NFKB1 and acute myeloid leukemia: This pattern is broadly consistent with previous evidence associating miR-155 with leukemic progression and inflammatory amplification through NF-κB/STAT5 signaling [10], as also reinforced by recent data highlighting its relevance in aggressive AML phenotypes [27].